Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function

Clinical Immunology

Volumn 131, Issue 2, 2009, Pages 260-270

  Cheatem, Donald ^a   Ganesh, Balaji B ^a   Gangi, Eryn ^a   Vasu, Chenthamarakshan ^a   Prabhakar, Bellur S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Dendritic cells; GM CSF; NOD; Regulatory T cells; Tolerance; Type 1 diabetes

Indexed keywords

CYTOKINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

AGE OF ONSET; ANIMALS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; MICE; MICE, INBRED NOD; RECOMBINANT PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 63749109591     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.12.001     Document Type: Article

References (40)

1. Yoon J.W., and Jun H.S. Autoimmune destruction of pancreatic beta cells. Am. J. Ther. 12 (2005) 580-591
2. Gagnerault M.C., Luan J.J., Lotton C., and Lepault F. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196 (2002) 369-377
3. Fabien N., Bergerot I., Maguer-Satta V., Orgiazzi J., and Thivolet C. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice. J. Autoimmun. 8 (1995) 323-334
4. Rosmalen J.G., Leenen P.J., Katz J.D., Voerman J.S., and Drexhage H.A. Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes. Adv. Exp. Med. Biol. 417 (1997) 291-294
5. Delovitch T.L., and Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7 (1997) 727-738
6. Serreze D.V., Gaskins H.R., and Leiter E.H. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 150 (1993) 2534-2543
7. Steinman R.M., and Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 351-358
8. Steinman R.M. The control of immunity and tolerance by dendritic cell. Pathol. Biol. (Paris) 51 (2003) 59-60
9. Summers K.L., Behme M.T., Mahon J.L., and Singh B. Characterization of dendritic cells in humans with type 1 diabetes. Ann. N.Y. Acad. Sci. 1005 (2003) 226-229
10. Rutella S., Danese S., and Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108 (2006) 1435-1440
11. Groux H., Fournier N., and Cottrez F. Role of dendritic cells in the generation of regulatory T cells. Semin. Immunol. 16 (2004) 99-106
12. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
13. Mahnke K., Johnson T.S., Ring S., and Enk A.H. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J. Dermatol. Sci. 46 (2007) 159-167
14. Wilczynski J.R., Radwan M., and Kalinka J. The characterization and role of regulatory T cells in immune reactions. Front. Biosci. 13 (2008) 2266-2274
15. Dahlen E., Hedlund G., and Dawe K. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J. Immunol. 164 (2000) 2444-2456
16. Alard P., Manirarora J.N., Parnell S.A., Hudkins J.L., Clark S.L., and Kosiewicz M.M. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 55 (2006) 2098-2105
17. Jansen A., van Hagen M., and Drexhage H.A. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 345 (1995) 491-492
18. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., and Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54 (2005) 92-99
19. Boudaly S., Morin J., Berthier R., Marche P., and Boitard C. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice. Eur. Cytokine Netw. 13 (2002) 29-37
20. You S., Leforban B., Garcia C., Bach J.F., Bluestone J.A., and Chatenoud L. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6335-6340
21. Tang Q., and Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212 (2006) 217-237
22. Vasu C., Dogan R.N., Holterman M.J., and Prabhakar B.S. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J. Immunol. 170 (2003) 5511-5522
23. Sheng J.R., Li L., Ganesh B.B., Vasu C., Prabhakar B.S., and Meriggioli M.N. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J. Immunol. 177 (2006) 5296-5306
24. Gangi E., Vasu C., Cheatem D., and Prabhakar B.S. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. 174 (2005) 7006-7013
25. Dogan R.N., Vasu C., Holterman M.J., and Prabhakar B.S. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J. Immunol. 170 (2003) 2195-2204
26. O'Keeffe M., Brodnicki T.C., Fancke B., Vremec D., Morahan G., Maraskovsky E., Steptoe R., Harrison L.C., and Shortman K. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development. Int. Immunol. 17 (2005) 307-314
27. Gaudreau S., Guindi C., Menard M., Besin G., Dupuis G., and Amrani A. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J. Immunol. 179 (2007) 3638-3647
28. Morin J., Faideau B., Gagnerault M.C., Lepault F., Boitard C., and Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin. Exp. Immunol. 134 (2003) 388-395
29. Chilton P.M., Rezzoug F., Fugier-Vivier I., Weeter L.A., Xu H., Huang Y., Ray M.B., and Ildstad S.T. Flt3-ligand treatment prevents diabetes in NOD mice. Diabetes 53 (2004) 1995-2002
30. O'Keeffe M., Hochrein H., Vremec D., Pooley J., Evans R., Woulfe S., and Shortman K. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99 (2002) 2122-2130
31. Curti A., Fogli M., Ratta M., Tura S., and Lemoli R.M. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors. J. Immunol. 166 (2001) 848-854
32. Vasu C., Holterman M.J., and Prabhakar B.S. Modulation of dendritic cell function and cytokine production to prevent thyroid autoimmunity. Autoimmunity 36 (2003) 389-396
33. Peng R., Bathjat K., Li Y., and Clare-Salzler M.J. Defective maturation of myeloid dendritic cell (DC) in NOD mice is controlled by IDD10/17/18. Ann. N.Y. Acad. Sci. 1005 (2003) 184-186
34. Enk A.H. Dendritic cells in tolerance induction. Immunol. Lett. 99 (2005) 8-11
35. Morris G.P., and Kong Y.C. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J. Autoimmun. 26 (2006) 24-31
36. O'Sullivan B.J., Thomas H.E., Pai S., Santamaria P., Iwakura Y., Steptoe R.J., Kay T.W., and Thomas R. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 176 (2006) 7278-7287
37. Janson R.W., Hance K.R., and Arend W.P. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J. Immunol. 147 (1991) 4218-4223
38. Poutsiaka D.D., Clark B.D., Vannier E., and Dinarello C.A. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 78 (1991) 1275-1281
39. B.B. Ganesh, D. Cheatem, J.R. Sheng, C. Vasu, B.S. Prabhakar, GM-CSF-induced CD11c+8a- dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis, Int. Immunol. (in press). doi:10.1093/intimm/dxn147.
40. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rossner S., Schuler G., and Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30 (2000) 1813-1822